Founded in the 1880s and listing on the ASX in 1952, ALS operates two divisions: commodities and life sciences... Show more
CPBLF moved above its 50-day moving average on October 13, 2025 date and that indicates a change from a downward trend to an upward trend. In of 11 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The 10-day moving average for CPBLF crossed bullishly above the 50-day moving average on October 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.671) is normal, around the industry mean (41.211). P/E Ratio (32.053) is within average values for comparable stocks, (46.165). CPBLF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.937). Dividend Yield (0.023) settles around the average of (0.028) among similar stocks. P/S Ratio (2.738) is also within normal values, averaging (47.542).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CPBLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry DataProcessingServices
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QLVD | 31.24 | 0.27 | +0.88% |
FlexShares Dev Mks ex-US Qual Lw Vol ETF | |||
SHE | 128.52 | 0.78 | +0.61% |
SPDR® MSCI USA Gender Diversity ETF | |||
NUSC | 43.81 | -0.09 | -0.21% |
Nuveen ESG Small-Cap ETF | |||
SIJ | 11.93 | -0.04 | -0.34% |
ProShares UltraShort Industrials | |||
ARMG | 14.47 | -1.07 | -6.89% |
Leverage Shares 2X Long Arm Daily ETF |
A.I.dvisor indicates that over the last year, CPBLF has been loosely correlated with MRLWF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CPBLF jumps, then MRLWF could also see price increases.
Ticker / NAME | Correlation To CPBLF | 1D Price Change % | ||
---|---|---|---|---|
CPBLF | 100% | N/A | ||
MRLWF - CPBLF | 50% Loosely correlated | N/A | ||
DIGTF - CPBLF | 32% Poorly correlated | N/A | ||
COGNY - CPBLF | 9% Poorly correlated | +0.09% | ||
BXBLY - CPBLF | 1% Poorly correlated | -0.81% | ||
CNGO - CPBLF | -1% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To CPBLF | 1D Price Change % |
---|---|---|
CPBLF | 100% | N/A |
Data Processing Services industry (40 stocks) | -0% Poorly correlated | -1.74% |